55000-02-7

Basic information

• Product Name: N-benzyl-S-chloroisothiocarbamoyl chloride
• Synonyms: N-benzyl-S-chloroisothiocarbamoyl chloride
• CAS NO: 55000-02-7
• Molecular Weight: 220.122
• Mol File: 55000-02-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-benzyl-S-chloroisothiocarbamoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: N-benzyl-S-chloroisothiocarbamoyl chloride(55000-02-7)
• EPA Substance Registry System: N-benzyl-S-chloroisothiocarbamoyl chloride(55000-02-7)

Safety Data

• Hazardous Substances Data: 55000-02-7(Hazardous Substances Data)

Upstream product

• 622-78-6 Benzyl isothiocyanate 

Downstream Products

• 327036-89-5 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione 
• 72966-20-2 GSK-3b Inhibitor III 

Relevant articles and documents

Identification of small molecules that inhibit GSK-3β through virtual screening

Glycogen synthase kinase-3β (GSK-3β) is involved in glycogen metabolism, neuronal cell development, osteoblast differentiation. Small molecule inhibitors of GSK-3β have various therapeutic potential for the treatment of diabetes type II, bipolar disorders

First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

Glycogen synthase kinase 3 β (GSK-3β) has a central role in Alzheimer′s disease (AD). Selective inhibitors which avoid τ hyperphosphorylation may represent an effective therapeutical approach to the AD pharmacotherapy and other neurodegenerative disorders